Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure
- 1 April 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (8), 895-899
- https://doi.org/10.1016/0002-9149(87)91115-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failureThe American Journal of Cardiology, 1986
- Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failureThe American Journal of Cardiology, 1985
- Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.Circulation, 1985
- Pharmaceutical considerations of transdermal nitroglycerin delivery: The various approachesAmerican Heart Journal, 1984
- Hemodynamic and Hormonal Response to Transdermal Nitroglycerin in Normal Subjects and in Patients With Congestive Heart FailureJournal of the American College of Cardiology, 1983
- Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.Circulation, 1983
- Human pharmacological studies of a new transdermal system containing nitroglycerinEuropean Journal of Clinical Pharmacology, 1982
- Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failureThe American Journal of Medicine, 1980
- Hemodynamic effects of nitroglycerin ointment in congestive heart failureThe American Journal of Cardiology, 1976
- Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart FailureCirculation, 1974